Global Rap Sensation Flipperachi Announces His Debut Concert In Mumbai This March

Mumbai, India, Feb 11: After taking global streaming platforms by storm and redefining Middle Eastern hip-hop for a new generation, breakout rap sensation Flipperachi is set to perform in Mumbai for the very first time on 13th March 2026 at Phoenix Marketcity.

Produced and promoted by Eva Live and Zee Live, powered by Mastercard, the concert marks a significant milestone in Flipperachi’s meteoric rise on the international stage. Mumbai, long hailed as India’s entertainment capital, is set to witness the artist’s explosive live energy, combining signature sounds with high-octane visuals and immersive crowd interactions that have become hallmarks of his global performances.

Flipperachi has emerged as one of the most influential new voices in contemporary rap, following the worldwide success of his viral hit ‘FA9LA’ and a feature in the Bollywood film Dhurandhar. Known for his raw lyricism, genre-blending sound, and unapologetic storytelling, the Bahraini rapper has cultivated a massive international fanbase spanning cultures, languages, and borders.

Flipperachi shared,

“India has shown me incredible love, and Mumbai is a city I’ve always wanted to perform in. The energy, the people, the culture—it all feels very familiar. This show is going to be loud, emotional, and unforgettable. Mumbai, get ready!”

Deepak Choudhary, Founder & Managing Director, Eva Live, added:

“Flipperachi is not just an artist but a movement. His rise has been completely organic, driven by authenticity and a deep connection with fans. Bringing his debut show to Mumbai was a no-brainer for us. This city understands global music, and we’re thrilled to present a show that reflects where hip-hop is headed next.”

Gareth Eswin Thomas, Business Head, Zee Live, said:

“Flipperachi represents the new wave of global hip-hop, where culture and music travel beyond borders. At Zee Live, our effort is to curate immersive entertainment experiences for audiences across India. We are excited to present Flipperachi’s debut show in Mumbai, elevating the live hip-hop experience for fans nationwide.”

Flipperachi will also perform in Bengaluru on 14th March 2026 at the UN40 Music Festival, making his Mumbai debut an unmissable event expected to draw fans from across the city and beyond.

Ticketing Information:

  • HDFC Bank Mastercard Presale: 14th Feb 2026, 12:00 PM – 16th Feb 2026, 12:00 PM IST

  • Mastercard Presale: 16th Feb 2026, 12:30 PM – 19th Feb 2026, 12:00 PM IST

  • General Sale: 19th Feb 2026, 12:30 PM IST onwards

  • Tickets available exclusively on District by Zomato

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

  • NMDC Hyderabad Marathon becomes India’s First Marathon to earn World Athletics’ Silver Sustainability Award

       From Boston to Berlin, Rome to Hyderabad, India’s Marathon earns place among World’s most Sustainable Athletics events   Hyderabad,…

    Read More

  • Government, corporates and global foundations join hands on PRAGATI to empower 20,000 agri-entrepreneurs

    Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan recently launched PRAGATI, a nationwide initiative to build 20,000 agri-entrepreneurs and…

    Read More

  • Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia

    Milan, Italy, July 08 — Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), has today announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene therapy approach to treat methylmalonic acidemia (MMA), a severe inherited metabolic disorder. The findings, published in the Journal of Hepatology, show that a single systemic administration of a lentiviral vector encoding the MMUT gene led to sustained improvements in disease features in a validated mouse model of MMA, with effects lasting for the average lifespan of laboratory mice. Since the mice were treated when young, the study supports the durability of the gene therapy through postnatal growth and maturation of the liver. MMA is caused by a deficiency of methylmalonyl-CoA mutase, an enzyme that plays a critical role in the body’s metabolism of food. Its absence results in the accumulation of toxic metabolites that lead to recurrent metabolic crises, growth failure, neurological impairment, and multi-organ damage. In the study, researchers also treated mice with a dose containing an optimized MMUT transgene, thereby improving therapeutic efficacy. In the same mouse model of MMA, this…

    Read More